BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 322502)

  • 1. Immunopathology of early and clinically silent lupus nephropathy.
    Cavallo T; Cameron WR; Lapenas D
    Am J Pathol; 1977 Apr; 87(1):1-18. PubMed ID: 322502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lupus nephritis: correlation between light, electron microscopic and immunofluorescent findings and renal function.
    Sinniah R; Feng PH
    Clin Nephrol; 1976 Aug; 6(2):340-51. PubMed ID: 782752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin in clinically uninvolved skin in systemic lupus erythematosus: association with renal disease.
    Gilliam JN; Cheatum DE; Hurd ER; Stastny P; Ziff M
    J Clin Invest; 1974 May; 53(5):1434-40. PubMed ID: 4596508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of fluorescein-labeled antinucleoside antibodies in glomeruli of patients with active systemic lupus erythematosus nephritis.
    Andres GA; Accinni L; Beiser SM; Christian CL; Cinotti GA; Erlanger BF; Hsu KC; Seegal BC
    J Clin Invest; 1970 Nov; 49(11):2106-18. PubMed ID: 4097660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological parameters in lupus nephritis: their relevance for classification and relationship with clinical and histological findings and outcome.
    Banfi G; Mazzucco G; Barbiano di Belgiojoso G; Bestetti Bosisio M; Stratta P; Confalonieri R; Ferrario F; Imbasciati E; Monga G
    Q J Med; 1985 May; 55(217):153-68. PubMed ID: 3159033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis-B-associated glomerulonephritis: pathology, pathogenesis, and clinical course.
    Venkataseshan VS; Lieberman K; Kim DU; Thung SN; Dikman S; D'Agati V; Susin M; Valderrama E; Gauthier B; Prakash A
    Medicine (Baltimore); 1990 Jul; 69(4):200-16. PubMed ID: 2142748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of lupus nephritis: its classification and the significance of subendothelial deposits.
    Tateno S; Kobayashi Y; Shigematsu H; Hiki Y
    Q J Med; 1983; 52(207):311-31. PubMed ID: 6359226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-DNA antibodies and renal lesions of patients with systemic lupus erythematosus.
    Koffler D; Agnello V; Carr RI; Kunkel HG
    Transplant Proc; 1969 Dec; 1(4):933-8. PubMed ID: 4939688
    [No Abstract]   [Full Text] [Related]  

  • 9. Mesangial electron-dense deposits in membranous nephropathy.
    Honig C; Mouradian JA; Montoliu J; Susin M; Sherman RL
    Lab Invest; 1980 Apr; 42(4):427-32. PubMed ID: 6445444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.
    Baranowska-Daca E; Choi YJ; Barrios R; Nassar G; Suki WN; Truong LD
    Hum Pathol; 2001 Oct; 32(10):1125-35. PubMed ID: 11679948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephritis in children and young adults with systemic lupus erythematosus and normal urinary sediment.
    Woolf A; Croker B; Osofsky SG; Kredich DW
    Pediatrics; 1979 Nov; 64(5):678-85. PubMed ID: 386241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse proliferative lupus glomerulonephritis. Determination of prognostic significance of clinical, laboratory and pathologic factors.
    Magil AB; Ballon HS; Chan V; Lirenman DS; Rae A; Sutton RA
    Medicine (Baltimore); 1984 Jul; 63(4):210-20. PubMed ID: 6377004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of immunofluorescence in the study of human renal disease.
    McCluskey RT
    J Exp Med; 1971 Sep; 134(3 Pt 2):242s-255s. PubMed ID: 4936813
    [No Abstract]   [Full Text] [Related]  

  • 14. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis.
    Adu D; Williams DG; Taube D; Vilches AR; Turner DR; Cameron JS; Ogg CS
    Q J Med; 1983; 52(208):471-87. PubMed ID: 6606818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression from minimal or focal to diffuse proliferative lupus nephritis.
    Zimmerman SW; Jenkins PG; Shelf WD; Bloodworth JM; Burkholder PM
    Lab Invest; 1975 May; 32(5):665-72. PubMed ID: 1092911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation among WHO classes, histomorphologic patterns of glomerulonephritis and glomerular immune deposits in SLE.
    Ferluga D; Jerse M; Vizjak A; Hvala A; Rozman B; Kos-Golja M; Bren AF
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):692-701. PubMed ID: 11020959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal damage in systemic lupus erythematosus with normal renal function.
    Hollcraft RM; Dubois EL; Lundberg GD; Chandor SB; Gilbert SB; Quismorio FP; Barbour BH; Friou GJ
    J Rheumatol; 1976 Sep; 3(3):251-61. PubMed ID: 789881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunofluorescence studies of dense deposit disease. The presence of railroad tracks and mesangial rings.
    Kim Y; Vernier RL; Fish AJ; Michael AF
    Lab Invest; 1979 Apr; 40(4):474-80. PubMed ID: 372673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing histopathology patterns in lupus nephropathy.
    Mahajan SK; Ordónez NG; Spargo BH; Katz AI
    Clin Nephrol; 1978 Jul; 10(1):1-8. PubMed ID: 699393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lupus Nephritis. Correlations between the clinical course and presence of electron-dense deposits.
    Dillard MG; Tillman RL; Sampson CC
    Lab Invest; 1975 Mar; 32(3):261-9. PubMed ID: 1123909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.